MRI

Latest News


CME Content


Nephrogenic systemic fibrosis has received widespread attention, but official protocols on how to avoid the life-threatening skin condition are quite sparse: Only one section in the American College of Radiology’s 2007 white paper on safe MR practices is devoted to the condition.

Any fluid-filled cavity or sac that is lined by an epithelium is a cyst, and intracranial cystic lesions are a common finding on CT and MR imaging of the brain.1,2 These lesions contain either cerebrospinal fluid, fluid that is similar to CSF, mucus, or proteinaceous fluid. They are lined by epithelial cells, inflammatory cells, or glial cells. The attenuation characteristics of the cyst on CT and MRI and the contrast enhancement patterns depend on the cyst's contents and the composition of the wall.

The discovery process for more than 60 federal lawsuits alleging a connection between cases of nephrogenic systemic fibrosis and gadolinium-based MR contrast agents will be consolidated at a single district court in Ohio, according to a U.S. judicial panel. Centralization will accelerate the discovery process and give plaintiffs access to a wider pool of pretrial information.

Give me a good gadget and I’m happy. I think a lot of people in radiology would say the same thing. It’s the reason crowds gathered 15 years ago to see 3D reconstructions revolving aimlessly in space. It’s why MR was a hit in the early 1980s.

Whole-body MRI is more sensitive but less specific than FDG-PET/CT for cancer detection, according to researchers from China and Europe. Findings suggest a complementary rather than exclusive role in oncologic imaging for both modalities and validate recent studies suggesting close follow-up since either test can miss metastases.

Marathon runners 50 years or older may face a higher than expected risk of sudden cardiovascular accidents. MR imaging with late gadolinium enhancement may help identify these athletes in time to keep them from potentially deadly episodes, according to German researchers reporting at the 2008 European Congress of Radiology in Vienna.

Radiologists must develop strategies for participating in the new age of imaging-based research. They need to join interdisciplinary teams, develop core imaging facilities for host institutions, involve themselves in small-animal imaging facilities, enter clinical research programs, and learn about PET and molecular imaging, which are at the core of pharmaceutical development.

Delegates caught a glimpse of the future of radiological technology at Sunday’s “ESR meets Israel” session.Israel may be relatively a small nation, with a population of just seven million, but it is making important contributions to innovation. About 900 companies are developing new pharmaceuticals, medical devices, and healthcare IT products. The majority of these businesses are relatively young and are supported by venture capital funding.

Interest in multimodality imaging shows no sign of abating. New tracers are opening up the range of clinical applications, while novel technological solutions are paving the way for yet more modality marriages, according to speakers at Sunday’s special focus session on hybrid imaging.